Thursday, October 22, 2026
25.6 C
Bengaluru

DigiStorm 2018: Intent, Content, Strategy and Skills

[su_dropcap style="flat"]T[/su_dropcap]he pharma industry in India is entering a very interesting variant of the post-digital marketing era. The term “post-digital marketing” is used to depict a state where the lines between physical and digital blur considerably for a customer. However, in the context of pharma, this means a state where the industry has stopped questioning the need for digital and has begun to implement very interesting digital marketing initiatives.

DigiStorm has always been about practising managers sharing their successes and failures and the lessons learned from them, than about theory and concepts.

At DigiStorm 2018 in Bengaluru, the sessions were lined up to explore how pharma is dealing with the post-digital marketing world. DigiStorm has always been about practising managers sharing their successes and failures and the lessons learned from them, than about theory and concepts. Built on a framework of Intent, Content, Strategy and Skills – DigiStorm hosted several CEOs, VPs, BU heads and Marketing/Sales heads who not only shared their experiences on the dais but also comprised the large audience that benefited from the discussions.

Competing Successfully in the Digital Economy

Following on from the highly interactive and eventful CEO Round Table which established the need for top-down engagement and involvement of the C-suite in an organization’s journey into technology and transformation, the second session dealt with VP-Marketing and BU Heads discussing their ‘on-the-ground’ experiences in taking the CEO’s vision forward in terms of execution.

Free Membership Required

You must be a Free member to access this content.

Join Now

Already a member? Log in here

Hot this week

Private Equity in Indian Healthcare: Who Is Investing Beyond the Metros?

Private capital is transforming India's healthcare landscape. But is...

Anuj Pasrija Elevated to Country Lead, J&J MedTech India and Vice President – Surgery

Anuj Pasrija has been elevated to Country Lead, Johnson...

China’s Biopharma Strategy: A Warning and Opportunity for India

China is playing a long game in biopharma. And...

Chirag Mehta has been appointed as Executive Director at ERIS Lifesciences.

With over two decades of experience across finance, strategy,...

Who Is Accountable for the Medicine in Your Hand?

The Accountability Gap: India’s Drug Regulatory System Your doctor prescribes...

Topics

Private Equity in Indian Healthcare: Who Is Investing Beyond the Metros?

Private capital is transforming India's healthcare landscape. But is...

Who Is Accountable for the Medicine in Your Hand?

The Accountability Gap: India’s Drug Regulatory System Your doctor prescribes...

Who Profits From Trust?

Indian healthcare does not suffer from a shortage of...
spot_img

Related Articles

spot_imgspot_img